Literature DB >> 19800750

Radiation-induced cholangitis with hepatocellular carcinoma.

G Gorea1, M Demy, J Tran Van Nhieu, J Tigori, C Aubé, D Cherqui, F Oberti, F-X Caroli-Bosc, P Calès.   

Abstract

There are no reports of hepatocellular carcinoma complicating postradiotherapy cholangitis. We report the case of a 45-year-old patient who had undergone upper abdominal radiotherapy for Hodgkin's disease, 21 years before, which was complicated years later by cholangitis with stricture of the common bile duct. Biliodigestive anastomosic surgery was scheduled due to recurrent angiocholitis, and hepatocellular carcinoma was discovered. The patient died from carcinoma some months later. Copyright 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19800750     DOI: 10.1016/j.gcb.2009.06.013

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  4 in total

1.  Cholangiocarcinoma following external beam radiotherapy: A report of two cases.

Authors:  Anisha Kulkarni; Justin S Gundara; Anthony J Gill; Thomas J Hugh; Jaswinder S Samra
Journal:  Oncol Lett       Date:  2017-05-03       Impact factor: 2.967

2.  [Endoscopic and percutaneous intervention in the long-term treatment of benign biliary stenosis. A 71-year-old patient with cholestasis following radiotherapy].

Authors:  P Klare; A Weber; M Dobritz; P Born; R Füllner; R M Schmid; S von Delius
Journal:  Internist (Berl)       Date:  2012-07       Impact factor: 0.743

3.  Proton Beam Therapy in Managing Unresectable Hepatocellular Carcinoma with Bile Duct Invasion.

Authors:  Ching-Hsin Lee; An-Hsin Chen; Sheng-Ping Hung; Cheng-En Hsieh; Jeng-Hwei Tseng; Po-Jui Chen; Jen-Yu Cheng; Joseph Tung-Chieh Chang; Kun-Ming Chan; Shi-Ming Lin; Chen-Chun Lin; Wei-Ting Chen; Wan-Yu Chen; Bing-Shen Huang
Journal:  Cancers (Basel)       Date:  2022-03-23       Impact factor: 6.639

4.  Caution for diagnosis and surgical treatment of recurrent cholangitis: lessons from 5 cases of bile duct tumor thrombus without a detectable intrahepatic tumor.

Authors:  Zheng Wu; Kun Guo; Hao Sun; Liang Yu; Yi Lv; Bo Wang
Journal:  Medicine (Baltimore)       Date:  2014-09       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.